基本情報
- CAS
82585-92-0- 標準SMILES
CCOC(=O)Nc1cc2c(c(N)n1)N=C(c1ccc(C)cc1)CN2- InChIKey
LOSVFNDAEKTRMV-UHFFFAOYSA-N- 分子式
- C17H19N5O2
- 平均分子量
- 325.4 g/mol
- 単同位体質量
- 325.15387487
名称と識別子
- 優先名称
- CI 980
- IUPAC
- ethyl N-[5-amino-3-(4-methylphenyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate
- 英語名
- CI 980
- 分子式
- C17H19N5O2
- 分子量
- 325.36506
名称と別名
82585-92-0CI 980SPT97238ADCarbamic acid, (5-amino-1,2-dihydro-3-(4-methylphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl esterDTXSID40231891RefChem:918601DTXCID70154382NSC-341932Ethyl (5-amino-3-(p-tolyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamateethyl (5-amino-1,2-dihydro-3-(4-methylphenyl)pyrido(3,4-b)pyrazin-7-yl)carbamateBRN 5131460UNII-SPT97238AD
名称をさらに表示
CHEMBL9619NSC341932NSC 341932Q27289332Ethyl(5-amino-3-(p-tolyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamateCarbamic acid,2-dihydro-3-(4-methylphenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl esterethyl [5-amino-3-(4-methylphenyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate
データベース識別子
- CAS
82585-92-0- PubChem CID
- 100669
- DTXSID
DTXSID40231891- ChEMBL
CHEMBL9619- UNII
- SPT97238AD
物性
構造計算による物性
- XLogP
- 2.3
- 極性表面積
- 102 Ų
- 水素結合供与体数
- 3
- 水素結合受容体数
- 6
- 回転可能結合数
- 4
- 重原子数
- 24
- 形式電荷
- 0
- 複雑度
- 476
化学と産業
薬理情報
MeSH Pharmacological Classification
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…